PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

memantine

Verify with FDA → · CMS NADAC pricing →

Brand names: Namenda

NMDA Receptor Antagonist Rx

Memantine is a medicine used to treat moderate to severe Alzheimer's disease. It may help with memory and thinking.

Drug Shortage Alert

memantine is currently listed as to be discontinued by the FDA. Affected manufacturer: Upsher-Smith Laboratories, LLC.

View all drug shortages →

Drug Pricing (NADAC)

Generic Price

$0.32/unit

Generic Available

Yes (31 manufacturers)

Pricing data from NADAC (CMS), effective December 18, 2024. Compare all drug costs →

What it does

Memantine is used to treat moderate to severe Alzheimer's disease.

Common side effects

Dizziness, Headache, Confusion

Key warnings

If you have conditions that make your urine less acidic (more alkaline), memantine levels in your blood may increase.

How It Works

Memantine is an NMDA receptor antagonist. This means it blocks the effects of a chemical in the brain called glutamate. By blocking glutamate, memantine may help protect brain cells from damage.

How to Take It

Start by taking 5 mg of memantine once a day. Your doctor may increase the dose by 5 mg each week. The usual effective dose is 10 mg twice a day. You can take memantine with or without food.

Pregnancy & Breastfeeding

It is not known if memantine can harm an unborn baby. Talk to your doctor if you are pregnant or plan to become pregnant. It is also not known if memantine passes into breast milk, so talk to your doctor if you are breastfeeding.

Missed Dose

If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and take your next dose at the regular time. Do not take two doses at the same time.

Storage

Store memantine tablets at room temperature, between 68° to 77°F (20° to 25°C).

Side Effects (from patient reports)

Based on 6,643 FDA adverse event reports.

Falling
937
Death
853
The medicine did not work
811
Using the medicine for something it's not approved for
740
Confusion
707
Tiredness
605
Seeing or hearing things that are not there
581
Condition got worse
502
Weakness
469
Sleepiness
438

FDA Adverse Event Report Analysis

Detailed analysis of 12,807 reports from the FDA Adverse Event Reporting System (FAERS). Reports span 2004–2025.

Total Reports

12,807

Death-Related Reports

1,934

Hospitalization Reports

5,255

Top Indication

Product Used For Unknown Indication

Gender Distribution

Female 5,975 (52%)
Male 5,528 (48%)

Age Distribution

0–17 181
18–44 468
45–64 1,144
65–74 1,818
75+ 5,631

Most Reported Adverse Reactions (FAERS)

# Reaction Reports
1 FALL 937
2 DEATH 853
3 DRUG INEFFECTIVE 811
4 OFF LABEL USE 740
5 CONFUSIONAL STATE 706
6 FATIGUE 605
7 HALLUCINATION 581
8 CONDITION AGGRAVATED 502
9 ASTHENIA 469
10 SOMNOLENCE 438
11 DIZZINESS 436
12 URINARY TRACT INFECTION 420
13 NAUSEA 404
14 DIARRHOEA 379
15 GAIT DISTURBANCE 346

Reactions in Death Reports

DEATH 849
PNEUMONIA 118
FALL 107
OFF LABEL USE 80
HALLUCINATION 79
PARKINSON^S DISEASE 77
CONDITION AGGRAVATED 74
CONFUSIONAL STATE 72
TOXICITY TO VARIOUS AGENTS 68
ASTHENIA 67

Reactions in Hospitalization Reports

FALL 607
CONFUSIONAL STATE 330
URINARY TRACT INFECTION 299
PNEUMONIA 255
ASTHENIA 246
FATIGUE 243
OFF LABEL USE 234
DRUG INEFFECTIVE 225
NAUSEA 188
DRUG INTERACTION 187

Source: FDA FAERS (Adverse Event Reporting System) FDA FAERS (Adverse Event Reporting System) Reports are voluntary and do not establish causation

Serious Warnings

If you have conditions that make your urine less acidic (more alkaline), memantine levels in your blood may increase. This could increase the risk of side effects. Talk to your doctor if you have kidney problems or take medicines that affect urine pH.

Known Drug Interactions

7.2 Use with Other N-methyl-D-aspartate (NMDA) Antagonists The combined use of memantine hydrochloride with other NMDA antagonists (amantadine, ketamine, and dextromethorphan) has not been systematically evaluated and such use should be approached with caution.

Mechanism: Both of these drugs affect the same receptors in the brain, and using them together has not been well studied. This could cause unknown side effects or change how the medications work.

What to do: Use this combination with caution and only if your doctor says it is necessary. Watch for any unusual changes in how you feel and report them to your provider.

Cases of interactions with other OCT2 substrates, memantine and metformin, have also been reported.

Mechanism: Both drugs use the same pathway in the kidneys to leave the body. This can cause memantine to build up in the blood because the kidneys are busy processing the trimethoprim.

What to do: Your doctor should monitor you for increased side effects from memantine while taking these together.

Common Questions

What should I avoid while taking memantine?
Talk to your doctor before taking other NMDA antagonists like amantadine or ketamine.
Can I drive while taking memantine?
Memantine may cause dizziness or confusion. Be careful driving or operating machinery until you know how memantine affects you.
How long will I need to take memantine?
Continue taking memantine as long as your doctor tells you to.
What if I have kidney problems?
If you have severe kidney problems, your doctor may prescribe a lower dose of 5 mg twice daily.
Can memantine cure Alzheimer's disease?
No, memantine does not cure Alzheimer's disease, but it may help manage the symptoms.
What happens if I stop taking memantine?
Talk to your doctor before stopping memantine. Your symptoms may worsen if you stop taking it suddenly.
Are there any foods I should avoid?
Diet can affect urine pH, which can affect memantine levels. Talk to your doctor about your diet.
Can I take memantine with other Alzheimer's medications?
Talk to your doctor about taking memantine with other medications.
What should I do if I think I'm experiencing a side effect?
Tell your doctor about any side effects you experience while taking memantine.
Is there a generic version of memantine?
Yes, memantine is available as a generic medication.
What are the common side effects of memantine?
The most commonly reported side effects of memantine include Dizziness, Headache, Confusion, Constipation. Based on 6,643 FDA adverse event reports. Always consult your healthcare provider about potential side effects.
Does memantine interact with other medications?
Yes, memantine has 2 known drug interactions. Notable interactions include dextromethorphan, trimethoprim. Always inform your doctor about all medications you are taking.
What drug class is memantine?
memantine belongs to the NMDA Receptor Antagonist drug class. It requires a prescription (Rx). Memantine is used to treat moderate to severe Alzheimer's disease.
Is memantine safe during pregnancy?
It is not known if memantine can harm an unborn baby. Talk to your doctor if you are pregnant or plan to become pregnant. Always consult your healthcare provider before using any medication during pregnancy or breastfeeding.
Is memantine currently in shortage?
Yes, memantine is currently listed as to be discontinued by the FDA. Affected manufacturer: Upsher-Smith Laboratories, LLC. Visit the FDA Drug Shortages database for the latest updates.

Related Medications in NMDA Receptor Antagonist

Other drugs grouped near memantine — same-class peers and common alternatives.

Compare memantine vs acamprosate side-by-side →

Medication Guides

Related Health & Safety Data

Save on memantine

Compare prices and find discounts at pharmacies near you. Free coupons can save up to 80% on prescriptions.

Disclosure: This link may earn us a commission at no extra cost to you. See our terms.

What the FDA Data Shows for memantine

The FDA label for memantine (sold under brand names such as Namenda) classifies it as a prescription-only medication in the NMDA Receptor Antagonist class. Memantine is used to treat moderate to severe Alzheimer's disease. Official labeling lists 4 commonly reported side effects, including Dizziness, Headache, Confusion.

Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. For this drug, FAERS contains 6,643 voluntary reports. The database also lists 2 documented drug interactions derived from FDA labeling, with the top-flagged interaction rated moderate severity. NADAC pricing from CMS shows a generic unit cost of $0.32.

Report counts do not establish causation — a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history, and patent information further shape supply and switching decisions. This page summarizes public FDA data for educational purposes only and is not a substitute for professional medical advice — always consult a licensed healthcare provider before starting, stopping, or changing any medication.

Data Sources

Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS). Pricing: CMS National Average Drug Acquisition Cost (NADAC). Shortage status: FDA Drug Shortages Database.

FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. Always consult a healthcare professional before making medication decisions.

Last updated: August 17, 2023

All federal data sources used on this page